Balance Sheet Data

Nymox Pharmaceutical Corporation (NYMX)

$0.4555

-0.80 (-63.85%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 0.857.975.243.610.830.370.220.130.080.04
Total Cash (%)
Account Receivables 0.090.010.020.020.0100000
Account Receivables (%)
Inventories 0.020.040.020.030.030.010000
Inventories (%)
Accounts Payable 2.020.811.631.401.270.260.150.090.050.03
Accounts Payable (%)
Capital Expenditure --0.04-0.01-0-0-0-0-0-0-0
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.